CareDx, Inc. (CDNA) vs Personalis, Inc. (PSNL)
- CareDx, Inc. CDNA 63.81 −4.30%
- Personalis, Inc. PSNL 15.65 −1.76%
CareDx, Inc. and Personalis, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $3.5B against $1.7B — 2.0× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against −13.3%. CareDx, Inc. has the higher net margin (24.2% vs −153.8%) and the higher return on invested capital (130.1% vs −317.5%). Across the 17 metrics below, CareDx, Inc. leads on 13 and Personalis, Inc. on 4.
Valuation
Profitability
| Metric | CDNA | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 12.69% | 50.89% |
| Operating margin | 23.61% | (164.07%) | (8.57%) |
| Net margin | 24.23% | (153.84%) | (6.37%) |
| Free cash flow margin | 18.49% | (144.76%) | 0.00% |
| Return on equity | 29.49% | (50.32%) | (2.92%) |
| Return on assets | 22.72% | (37.55%) | (6.71%) |
| Return on invested capital | 130.06% | (317.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack